Qube Research & Technologies (QRT)’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-132,809
| Closed | -$3.14M | – | 4386 |
|
|
2023
Q4 | $3.14M | Buy |
+132,809
| New | +$3.14M | 0.01% | 1096 |
|
|
2023
Q2 | – | Sell |
-19,687
| Closed | -$172K | – | 3074 |
|
|
2023
Q1 | $172K | Sell |
19,687
-72,418
| -79% | -$631K | ﹤0.01% | 1923 |
|
|
2022
Q4 | $577K | Buy |
92,105
+32,081
| +53% | +$201K | ﹤0.01% | 1360 |
|
|
2022
Q3 | $210K | Buy |
60,024
+41,862
| +230% | +$146K | ﹤0.01% | 1714 |
|
|
2022
Q2 | $54K | Buy |
+18,162
| New | +$54K | ﹤0.01% | 2092 |
|
|
2021
Q1 | – | Sell |
-22,658
| Closed | -$130K | – | 2521 |
|
|
2020
Q4 | $130K | Sell |
22,658
-39,919
| -64% | -$229K | ﹤0.01% | 1606 |
|
|
2020
Q3 | $453K | Buy |
62,577
+52,394
| +515% | +$379K | 0.01% | 1078 |
|
|
2020
Q2 | $36K | Buy |
+10,183
| New | +$36K | ﹤0.01% | 1631 |
|